Nadine Wong

How to Know if the Price Is Right on a Biotech Stock

By Nadine Wong

Nadine Wong is the editor, publisher and co-founder of the monthly BioTech Sage Report. Wong writes a weekly column that appears on this page as part of her business relationship with TheStreet.com.

08:35AM 11/15/01

Protein Design Labs' Pipeline Shows Some Promising New Drugs

By Nadine Wong

Nadine Wong is the editor, publisher and co-founder of the monthly BioTech Sage Report. Wong writes a weekly column that appears on this page as part of her business relationship with TheStreet.com.

08:39AM 11/08/01

Ciphergen Ready to Capitalize on New Protein Research

By Nadine Wong

Nadine Wong is the editor, publisher and co-founder of the monthly BioTech Sage Report. Wong writes a weekly column that appears on this page as part of her business relationship with TheStreet.com.

10:00AM 11/01/01

Think About Taking Profits in Gilead Sciences

By Nadine Wong

Nadine Wong is the editor, publisher and co-founder of the monthly BioTech Sage Report. Wong writes a weekly column that appears on this page as part of her business relationship with TheStreet.com.

11:40AM 10/26/01

These Bioterrorism Stocks Aren't Worth Playing Anymore

By Nadine Wong

Nadine Wong is the editor, publisher and co-founder of the monthly BioTech Sage Report. Wong writes a weekly column that appears on this page as part of her business relationship with TheStreet.com.

11:14AM 10/18/01

Keep Your Eye On COR Therapeutics

By Nadine Wong

Its lead drug has had disappointing sales, but COR still shows promise.

01:03PM 10/10/01

Some Biotech Stocks Set to Get Booster Shots

By Nadine Wong

Promising new drugs may give companies like Gilead, Immunex and ICOS a new lease on life.

01:49PM 10/03/01

Biotech Companies Look to Combat Terrorism

By Nadine Wong

Cepheid and Bruker Daltonics could offer good opportunities in stressful times.

10:44AM 09/26/01

Biotechs and Big Pharma: How to Invest

By Nadine Wong

Can't stomach the volatility? Consider reaping the benefits of a more conservative strategy.

09:39AM 09/17/01

Potential Winners in the Biotech Space

By Nadine Wong

Amgen and Genentech both have good earnings and solid product pipelines.

02:57PM 09/05/01